The Food and Drug Administration today announced a voluntary pilot program to expedite approvals of certain changes to ethylene oxide sterilization processes and facilities. Under the pilot program, facilities that use fixed-chamber ethylene oxide sterilization processes to sterilize single-use medical devices would submit a “master file” to the FDA when making certain changes to their location or changes to their sterilization processes that use lower ethylene oxide concentrations. The FDA believes the program will allow more efficient review and feedback, ultimately allowing the agency to provide a more nimble response to site closures in the future. In addition, FDA said it will work with 12 applicants to its innovation challenges to accelerate the development and review of innovative technologies for sterilization processes, and is moving forward with certain recommendations from its recent advisory committee meeting.

Related News Articles

Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Chairperson's File
Public
With all of the challenges facing health care — a shrinking workforce population, reduced funding, new technologies and pharmaceuticals — it's no longer an…
Headline
Newsweek’s Access Health newsletter today features a conversation with AHA Chair Tina Freese Decker, president and CEO of Corewell Health in Michigan, where…
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…
Headline
The Food and Drug Administration has identified a Class I recall of Philips Respironics V30, A30 and A40 ventilators due to the potential for serious injury or…
Headline
The Food and Drug Administration has identified a Class I recall of Edwards Lifesciences OptiSite Arterial Perfusion Cannula devices due to the potential for…